Related Experiment Video
Updated: Jul 10, 2026
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Proton pump inhibitor target genes and asthma susceptibility: a Mendelian randomization study with identification of
Lingwen Gu1, Jinglin Li2, Ziqian Yin1
1Department of Neurosurgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
Objective:
Previous observational studies on the relationship between proton pump inhibitors (PPIs) and asthma have yielded controversial results, with the underlying mechanisms remaining unclear. This study aimed to elucidate the causal relationship between PPIs and asthma using Mendelian randomization (MR) approaches.
Methods:
Instrumental variables proxying the expression of PPI target genes were derived from the eQTLGen Consortium and GTEx project. Asthma summary statistics were obtained from the Trans-National Asthma Genetic Consortium (TAGC) and FinnGen consortium. Drug-target MR and summary-data-based MR (SMR) analyses were employed to assess the causal associations between PPI target genes and asthma. Two-sample MR was further conducted to evaluate the causal effects of inflammatory proteins on asthma, followed by mediation analysis to explore potential mediators. A series of sensitivity analyses and colocalization analyses were performed to test the robustness of our findings.
Results:
Genetically proxied elevation of MAPT and DDAH1 levels was associated with an increased risk of asthma, while elevated AHR levels were linked to a decreased risk. The SMR analysis further supported the association between MAPT and asthma. We also identified causal associations between four inflammatory proteins and asthma. Mediation analysis suggested that interleukin-2 (IL-2) may serve as a potential mediator in the pathways from AHR and MAPT to asthma, with estimated mediation proportions of 26.5% and 28.7%, respectively.
Conclusion:
This study provides genetic evidence supporting causal links between PPI-related genes (AHR, DDAH1, MAPT) and asthma. IL-2 may play a mediating role in the pathways connecting AHR and MAPT to asthma, offering novel insights into the potential mechanisms underlying the PPI-asthma relationship.
Related Concept Videos
01:26Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
01:28Asthma I: Introduction
01:20Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:29Asthma-I: Introduction
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...